Podcasts about clinical data

Sponsored by: Set For LifeSet For Life Insurance helps doctors safeguard their future with True Own Occupational Disability Insurance. A single injury or illness can change everything, but the best physicians plan ahead. Protect your income and secure your future before life makes the choice for you. Your career deserves protection—act now at https://www.doctorpodcastnetwork.co/setforlife____________In this episode, Dr. Bradley Block interviews Dr. Nini Munoz, who shares strategies to help physicians effectively navigate and combat health misinformation. Known for her platform Nini and the Brain, Dr. Munoz rose to prominence during the COVID-19 pandemic by demystifying complex clinical data. She explains common statistical manipulations, like base rate fallacy and absolute versus relative risk, using examples such as raw milk claims and fluoride debates. Dr. Munoz emphasizes the difference between risk (quantifiable likelihood of harm) and hazard (potential to cause harm), offering strategies to communicate these concepts to patients by aligning with their personal values. From addressing publication bias to advocating humility in science, this episode equips physicians to counter misleading headlines and foster trust with patients.Three Actionable Takeaways:Spot Base Rate Fallacy – Adjust for population size when comparing health outcomes (e.g., pasteurized vs. raw milk hospitalizations) to avoid misleading absolute numbers and reveal true risk.Question Weak Effects – Scrutinize studies with inconsistent or marginal effects, like fluoride research, by checking for confounders, publication bias, or non-replicable results.Tailor Risk Communication – Frame health advice around patients' personal risks (e.g., vaccine benefits for individual healthcare access) to make data relatable and actionable.About the Show:The Physician's Guide to Doctoring covers patient interactions, burnout, career growth, personal finance, and more. If you're tired of dull medical lectures, tune in for real-world lessons we should have learned in med school!About the Guest:Dr. Nini Munoz is a PhD-trained electrical engineer and data scientist who gained prominence during the COVID-19 pandemic through her platform Nini and the Brain. Specializing in risk assessment and statistical literacy, she breaks down complex clinical data in English and Spanish, combating misinformation. Dr. Munoz collaborates with virologists, immunologists, and clinicians to make science accessible and advises healthcare organizations like Kaiser Permanente on risk communication strategies.Website: https://www.niniandthebrain.com/Substack: https://substack.com/@techingitapartInstagram: https://www.instagram.com/niniandthebrainThreads: https://www.threads.com/@niniandthebrainAbout the host:Dr. Bradley Block – Dr. Bradley Block is a board-certified otolaryngologist at ENT and Allergy Associates in Garden City, NY. He specializes in adult and pediatric ENT, with interests in sinusitis and obstructive sleep apnea. Dr. Block also hosts The Physician's Guide to Doctoring podcast, focusing on personal and professional development for physiciansWant to be a guest?Email Brad at brad@physiciansguidetodoctoring.com  or visit www.physiciansguidetodoctoring.com to learn more!Socials:@physiciansguidetodoctoring on Facebook@physicianguidetodoctoring on YouTube@physiciansguide on Instagram and Twitter Visit www.physiciansguidetodoctoring.com to connect, dive deeper, and keep the conversation going. Let's grow! Disclaimer:This podcast is for informational purposes only and is not a substitute for professional medical, financial, or legal advice. Always consult a qualified professional for personalized guidance.

In this episode, Catherine Fahey, MD, PhD; Alexandra Leary, MD, PhD; Funda Meric-Bernstam, MD; and Zev A. Wainberg, MD, explore the mechanisms of HER2-targeted antibody–drug conjugates (ADCs) and emerging clinical data with these agents across genitourinary, gastrointestinal, and gynecologic cancers.Mechanisms of action of ADCs: how ADCs selectively deliver potent chemotherapy to tumor cellsClinical data across tumor types: highlights from recent trials with trastuzumab deruxtecan and exploration of emerging data on agents such as disitamab vedotinChallenges and future directions:key considerations for combining HER2-targeted ADCs with immunotherapy or chemotherapy, and sequencing ADC therapiesPresenters:Catherine Fahey, MD, PhDAssistant ProfessorDivision of OncologyUniversity of North Carolina at Chapel HillChapel Hill, North CarolinaAlexandra Leary, MD, PhDPresident, GINECO GroupCo-Director, Department of Medical OncologyMedical Oncologist GynecologyTeam Leader, Gynecologic Translational Research Lab, INSERM u981Institut Gustave RoussyVillejuif, FranceFunda Meric-Bernstam, MDChair, Department of Investigational Cancer TherapeuticsMedical Director, Institute for Personalized Cancer TherapyNellie B. Connally Chair in Breast CancerThe University of Texas MD Anderson Cancer CenterHouston, TexasZev A. Wainberg, MDProfessor of Medicine and SurgeryCo-Director of GI OncologyDirector, Early Phase Clinical Research ProgramJonsson Comprehensive Cancer CenterUCLA School of MedicineLos Angeles, CaliforniaLink to full program:https://bit.ly/42iEDjVTo claim credit for listening to this episode, please visit the podcast online at the link above. 

In this information-packed episode of The Red Light Report, Dr. Mike Belkowski is joined by Josh Crawford, Clinical Director of Genoa Integrative Health & Wellness. Josh shares his transformational journey from emergency medicine to building one of the most robust red light therapy clinics in North America. Sparked by the tragic loss of his first wife to Crohn's disease and biologic-related cancer, Josh recounts how that experience ignited his pursuit of root-cause medicine, integrative therapies, and photobiomodulation.   The episode dives deep into the clinical application of red light therapy and methylene blue — especially in combination — as tools for mitochondrial repair, anti-aging, and chronic disease recovery. Josh and Dr. Mike explore the synergistic effects of methylene blue and red light, optimal dosing strategies, and the importance of high-quality supplementation. They also address the challenges of consumer devices, the biohacker movement, and using light and energy to promote cellular regeneration.   Topics include: •  Josh's journey from paramedic to bioenergetic health leader •  Why methylene blue + red light = mitochondrial magic •  Dosing strategies, contraindications, and clinical applications •  How to vet red light therapy devices and avoid snake oil •  Real-world stories of healing from autoimmune, cancer, and neurodegeneration   Whether you're a clinician, wellness entrepreneur, or biohacker, this episode is full of clinical pearls, personal insights, and practical protocols that highlight the future of medicine rooted in energy, light, and mitochondrial health.   Josh Crawford is the Clinical Director of Genoa Integrative Health & Wellness, a leading clinic focused on root-cause healing, mitochondrial repair, and advanced integrative therapies. With a background in emergency medicine and paramedicine, Josh transitioned into the world of holistic health after the tragic loss of his first wife to complications from Crohn's disease and biologic treatment. This personal turning point fueled his mission to challenge conventional sick-care models and pursue modalities that restore cellular health—especially photobiomodulation (red light therapy) and methylene blue. Today, Josh blends clinical insight with cutting-edge technologies to help patients reverse chronic illness, restore vitality, and reclaim their lives. He is widely respected for his hands-on expertise, patient-first philosophy, and ability to bridge traditional medical training with bioenergetic and integrative solutions.   If you found the information in today's episode particularly interesting and/or compelling, please share it with a family member, friend, colleague and/or anyone that you think could benefit and be illuminated by this knowledge. Sharing is caring :) As always, light up your health! - Key points: 00:00 – Introduction 03:18 – Career Shift: From Emergency Medicine to PBM Pioneer 07:05 – Building the Clinic: Canada's Red Light Hub 08:13 – Community Contrast: PBM vs. Conventional Medicine 09:26 – Mitochondria: The Root of Chronic Disease 10:23 – Methylene Blue Basics & Brain Boosting Benefits 11:31 – Red Light + Methylene Blue: Synergistic Power 12:41 – BioLight's Formula: What Makes It Different 13:36 – Why We Don't Say “Cure”: Focus on Balance 15:17 – Methylene Blue in Practice: Cancer & Chronic Cases 17:43 – Prevention > Treatment: The Case for Proactive Healing 20:57 – Synthetic Isn't Evil: Methylene Blue's History 23:25 – Clinical Data: 10,000+ Treatments, 0 Side Effects 25:02 – Empowering Patients: Education Over Blind Trust 26:22 – Curcumin + Methylene Blue: A Healing Combo 27:40 – Chronic Conditions: Extinguish the Fire First 28:08 – The Self-Healing Body: Set the Terrain 30:01 – Zero Harm: What 10,000 Doses Taught Us 31:12 – Inside the Clinic: What Patients Experience 33:27 – Food as Fuel: The Missing Piece in Healing 34:18 – Goldilocks Zone: The Ideal Red Light Dosage 35:19 – Energy & Frequency: Healing at a Cellular Level 37:01 – Frequency Therapy: Rife Tech & Signal Targeting 39:22 – Less is More: Why Overdoing Light Fails 41:28 – Beds Aren't Enough: Deep Healing Requires Precision 42:53 – Mobilizing Stem Cells with Light 44:34 – Brain Work: Lymph Flow & Drainage Support 46:22 – Consumer Devices: Why Most Don't Deliver 49:07 – Tech Specs: Pulsing, Power & What Really Matters 52:41 – The Red Light Market: Navigating Misinformation 55:13 – It's All About Dose: The Turkey Analogy 56:07 – Cooking the Tissue: Why Power Isn't Everything 58:13 – Class IV Lasers: Pain Relief vs. Real Healing 59:28 – Power ≠ Better: The Myth of “More is More” 1:00:08 – Lessons from 80,000+ Treatments 1:01:32 – Wrap-Up: Excitement Around New BioLight Capsules - Watch this episode on YouTube - Upcoming BioLight Events:   Biohacking Conference - May 28 - 30 (Austin, TX)   Returning to Nature (Quantum Health Retreat), June 26 - 27 (Franklin, TN) - Save 25% when you Subscribe & Save to a BioBundle!   For a BioBundle, you choose:1.) Any one BioBlue supplement(BioBlue, BioBlue (SR), BioBlue Leuco, BioBlue Calm, BioBlue Capsules or BioBlue Leuco Capsules)2.) Any one BioC60 supplement(Regular or Concentrated)   The BioBundle automatically saves you 15% on both of the supplements you choose.You save an additional 10% by choosing to Subscribe & Save to that BioBundle.The 25% savings is passed along for every monthly delivery of your BioBundle!No discount code necessary!   Click here to check out The BioBundle - Dr. Mike's #1 recommendations: Water products: Water & Wellness Grounding products: Earthing.com EMF-mitigating products: Somavedic Blue light-blocking glasses: Ra Optics - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight: Website Instagram YouTube Facebook

The following article of the Health industry is: “The Protection of Clinical Data in Mexico Still a Pending Issue” by  Alejandro Luna, Partner at Olivares, Olivares.

Session 2 ‘Sepsis Epidemiology and Clinical Data' from the 5th World Sepsis Congress. Featuring Mohsen Naghavi, Shevin Jacob, Lisa Mellhammar, Flavia Machado, Lowell Ling, and Eleanor Nwadinobi as your moderator.

In this episode, Hatem Rabeh will explain to us what are Clinical Data and also if there is a chance for you to avoid Clinical Investigations. There are also some confusion between Clinical Evaluation and Clinical Investigation. Let's clarify all this and give you the right strategies for your Medical Devices. So stay tuned.  Who is Hatem Rabeh?  Hatem Rabeh is a Medical Doctor with an MSc in Medical Engineering, specializing in clinical evaluation for medical devices.   With over 8 years of experience, he supports manufacturers in MDR compliance by preparing Clinical Evaluation Plans (CEP) and Clinical Evaluation Reports (CER) for Class I to Class III devices, including software, implants, and robotic systems.  His expertise covers literature reviews, clinical strategy, and regulatory compliance.   Hatem also shares his knowledge through online training, consulting, and LinkedIn content.  Who is Monir El Azzouzi?  Monir El Azzouzi is the founder and CEO of Easy Medical Device a Consulting firm that is supporting Medical Device manufacturers for any Quality and Regulatory affairs activities all over the world. Monir can help you to create your Quality Management System, Technical Documentation or he can also take care of your Clinical Evaluation, Clinical Investigation through his team or partners. Easy Medical Device can also become your Authorized Representative and Independent Importer Service provider for EU, UK and Switzerland.  Monir has around 16 years of experience within the Medical Device industry working for small businesses and also big corporate companies. He has now supported around 100 clients to remain compliant on the market. His passion to the Medical Device filed pushed him to create educative contents like, blog, podcast, YouTube videos, LinkedIn Lives where he invites guests who are sharing educative information to his audience. Visit easymedicaldevice.com to know more.  Link Hatem Rabeh LinkedIn: https://www.linkedin.com/in/hatem-rabeh/  Social Media to follow Monir El Azzouzi Linkedin: https://linkedin.com/in/melazzouzi Twitter: https://twitter.com/elazzouzim Pinterest: https://www.pinterest.com/easymedicaldevice Instagram: https://www.instagram.com/easymedicaldevice

Given the challenges that our dialysis patients face, how can we as providers stay sharp with the latest access techniques to help ensure the best possible outcomes? Dr. Omar Davis (interventional nephrologist) and Dr. Ari Kramer (general surgeon) join host Dr. Chris Beck to discuss advanced approaches to AV access and share their experiences with the FLEX Vessel Prep device. --- This podcast is supported by: VentureMed FLEX Vessel Prep https://www.venturemedgroup.com/ --- SYNPOSIS The doctors begin by describing how they create dialysis access and what they account for during the procedure. They then focus on the role of the FLEX VP system, its benefits, and how they use it in practice, touching on the latest clinical data. Dr. Kramer and Dr. Davis also stress the importance of mental health in dialysis care and share ways that we can better support our patients through difficult diagnoses and treatments. In fact, one of their patients, Fred Hill, authored the book “Dialysis Is Not Your Life,” which offers a unique perspective for patients feeling overburdened by dialysis, and the healthcare providers who treat them. The episode concludes with case presentations and practical guidance on when to use the FLEX Vessel Prep system. --- TIMESTAMPS 00:00 - Introduction 07:00 - AV Access and Procedures 10:58 - Case Walkthrough 14:19 - Balloon Angioplasty and IVUS 24:43 - Flex VP Device and Vessel Prep 35:03 - Algorithm and Reimbursement Challenges 39:51 - Device Usage and Techniques 46:58 - Clinical Data and Outcomes 01:01:59 - Case Studies --- RESOURCES Fred Hill, “Dialysis Is Not Your Life” Founder and Author: https://www.dialysisisnotyourlife.com/meet-founder.php “Dialysis Is Not Your Life” Book: https://www.amazon.com/DIALYSIS-NOT-YOUR-LIFE-Redefine/dp/B09L4XGGNX Novel Device Prior to Balloon Angioplasty for Dysfunctional Arteriovenous Access: Analysis of a Real-World Registry by Race and Sex Cohorts: https://www.openaccessjournals.com/articles/novel-device-prior-to-balloon-angioplasty-for-dysfunctional-arteriovenousaccess-analysis-of-a-realworld-registry-by-race-and-sex-16852.html FLEX Vessel Prep 12 Month AV Registry Data and 12 Month Belong PAD Data Shows Benefit to Micro-incisions Before Balloon or DCB Treatment: https://www.venturemedgroup.com/wp-content/uploads/2022/12/VEITH-Data-FINAL.pdf Angioplasty with novel, easy-to-use, bladed Flex Vessel Prep system “could replace standard of care”: https://www.youtube.com/watch?v=iRpkrURx1mc Surgical AVF Articles Atlas Condensed - sAVF Overview - Creation Maturation and Difficulties: https://docs.google.com/document/d/1f26FT65s03oZjjeZhBVy8auz0h8PTNvX3CWU5Xi_H5c/edit?usp=share_link Surgical AVF Articles Asif A, Early Arteriovenous fistula failure: https://drive.google.com/file/d/1zZEWgxsdBM4MKCQFjw0U04ra_hB9Ey_N/view?usp=share_link Surgical AVF Articles Asif A - Best Vascular Access in the Elderly - Time for Innovation: https://drive.google.com/file/d/1IpH-KnZyfN5Rqm_kxLnERnEJD6vcjAO8/view?usp=sharing Surgical AVF Articles EV Today - Managing Cephalic Arch Stenosis: https://drive.google.com/file/d/17yVd2M706YCtX-xTK6teesgZqzVIgUoN/view?usp=share_link VentureMed 2024 FLEX Vessel Prep System Reimbursement Guide: https://www.venturemedgroup.com/wp-content/uploads/2024/04/MMA-CTO-15690_FlexVesselPrepSystem-BillingGuide_Lv6-003.pdf BackTable VI Podcast Episode #139 - AV Fistula & Graft Maintenance with Dr. Ari Kramer: https://www.backtable.com/shows/vi/podcasts/139/av-fistula-graft-maintenance BackTable VI Podcast Episode #292 - Dialysis Interventions with Drug-Coated Balloons, Covered Stents and More with Dr. Ari Kramer: https://www.backtable.com/shows/vi/podcasts/292/dialysis-interventions-with-drug-coated-balloons-covered-stents-more

CME credits: 1.00 Valid until: 06-02-2026 Claim your CME credit at https://reachmd.com/programs/cme/leveraging-clinical-data-her2-targeted-adcs-in-second-line-and-beyond-mbc/29946/ The development and availability of HER2-directed therapies has dramatically improved outcomes for patients with metastatic breast cancer (MBC). Moreover, emerging data indicate that these therapies also improve outcomes for those with brain metastasis. In this educational series, expert faculty differentiate the available HER2-directed therapies for MBC, assess their efficacy in disease with brain metastasis, and review treatment selection and sequencing considerations for these agents. Please stay tuned for additional content to this program available for credit. The maximum amount of credits available for the entire activity is 1.00.

Artificial Intelligence (AI) is revolutionizing healthcare, and oncology is no exception. In this episode of the Exploring AI in Oncology series, Kristin Maloney, MS, BSN, RN, OCN®, a Certified Oncology Nurse and the Clinical Informatics Lead at Mendel AI, speaks with Dr. Waqas Haque on how AI can address some of the biggest challenges in oncology. She shares more about Mendel's innovative platform, which leverages physician-level cognitive capabilities to enhance data process and improve clinical decision making and patient outcomes. Learn more at: https://oncdata.com/mendel-ai-with-kristin-maloney

Did you know androgen deprivation monotherapy is no longer considered standard of care for metastatic hormone-sensitive prostate cancer (mHSPC) by experts? Credit available for this activity expires: 11/25/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001957?ecd=bdc_podcast_libsyn_mscpedu

Host Sandy Vance is behind the mic in this episode with Chris Chang, CEO and Co-Founder at GradientAI. Have any questions for Chris? Reach out via email or check out their website.They explore why GradientAI focuses specifically on the healthcare industry and how its innovative solutions are enhancing patient care and operational efficiency. They also address common concerns surrounding AI adoption and share exciting use cases and future developments. Listen in as Sandy and Chris navigate the intersection of GradientAI and AI in healthcare, revealing the potential to reshape the future of medicine.GradientAI enables enterprises to automate their complex data workflows using its AI-powered data-reasoning platform. They work with many integrated care providers and health tech companies to power processes across the organization, from medical note auditing to the improvement of care to patients, benefit management, claims processing, and data reconciliation. Enterprise AI automation in healthcare, powered by Nightingale - a domain-specific model designed specifically for healthcare.In this episode, they talk about:Why GradientAI Focuses on Healthcare and the Benefits of AI in HealthcareHow GradientAI Helps the Healthcare IndustryPros and Cons of Workflow Tools That Limit Information in HealthcareThe Transformative Technology of AI in the Healthcare IndustryUse Cases, Trials, and Development of AI in HealthcareAddressing Concerns of Those Wary About AI in HealthcareThe Future of GradientAI and AI in HealthcareA Little About Chris:Chris is the Co-Founder and CEO at Gradient, who most recently led Studio AI at Netflix and was an architect of early domain expert LLMs for content production and intelligence. Prior to joining Netflix, Chris held a variety of leadership roles at Pinterest, Opendoor, and Meta. Chris started his career in finance and holds a dual bachelor's degree in computer science and business and a master's degree in computer science from UPenn.

Therapeutic options for frontline management of epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC) are rapidly evolving. Are you up to date on the evidence?    Credit available for this activity expires: 09/27/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001657?ecd=bdc_podcast_libsyn_mscpedu

Join us on the Becker's Healthcare Podcast as we speak with Elad Benjamin, Business Leader in Clinical Insights & Integration at Philips, about the critical role of clinical data integration in improving patient outcomes. Learn about the impact of AI, virtual care models, and key strategies for healthcare leaders to support innovation.This episide is sponsored by Philips.

This episode's Community Champion Sponsor is Ossur. To learn more about their ‘Responsible for Tomorrow' Sustainability Campaign, and how you can get involved: CLICK HERE---Episode Overview: How can we harness the power of clinical data to ignite improvement in the healthcare industry? Our next guest, Greg Miller, is on a mission to transform the industry through innovative data solutions at Carta Healthcare. With nearly four decades of experience in healthcare technology, Greg brings a wealth of knowledge in leveraging data to improve outcomes and drive process improvement. While together, Greg shares how he and his team are tackling the challenges of clinical data abstraction, combining artificial intelligence with human expertise to deliver faster, more efficient, and higher quality results. Join us as Greg shares Carta Healthcare's groundbreaking approach to streamlining data collection for clinical registries, reducing costs, empowering healthcare providers with actionable insights and paving the way for a data-driven future in healthcare. Let's go!Episode Highlights:Carta Healthcare's AI-human hybrid approach achieves 85-86% accuracy in automating clinical data abstractionSolution addresses a $10-15 billion industry challenge, reducing costs and improving data qualityGreg discusses healthcare's divided response to AI: fear vs. eager uncertaintyTechnology aims to alleviate workforce shortages by freeing clinicians from data abstraction tasksFuture plans include expanding to more registries and exploring new healthcare applications About our Guest: Greg leads marketing and business development for Carta Healthcare. For almost 40 years, Greg has been driven to transform healthcare, leveraging data to improve outcomes. Miller began his healthcare career within an academic medical center in Boston and for decades he has been leading digital health companies, ranging from startups to Fortune 50 companies, as they apply innovative solutions to drive healthcare process and quality improvement and digital health adoption. Miller's leadership in privately-held, venture-backed companies has resulted in seven acquisitions with meaningful exits and two successful IPO's.Links Supporting This Episode: Carta Healthcare Website: CLICK HEREGreg Miller LinkedIn page: CLICK HERECarta Healthcare LinkedIn page: CLICK HERE Mike Biselli LinkedIn page: CLICK HEREMike Biselli Twitter page: CLICK HEREVisit our website: CLICK HERESubscribe to newsletter: CLICK HEREGuest nomination form: CLICK HERE

Collaboration between Sutter Health and PointClickCare allows ER physicians to know how many ER visits the patient previously made, not only at that hospital but in the region.

In this episode, listen to Alice T. Shaw, MD, PhD, and Jessica J. Lin, MD, share their thoughts on the available clinical data in support of frontline treatments for ROS1-altered NSCLC including:Efficacy and safety data for crizotinib, entrectinib, and repotrectinib in patients with ROS1-altered advanced NSCLCLong-term safety observations for crizotinib and entrectinib CNS activity of entrectinib and repotrectinib in patients with brain metastasesRepotrectinib activity in ROS1-TKI resistance mutations  Program faculty:Jessica J. Lin, MDAttending PhysicianMassachusetts General HospitalAssociate Professor of MedicineHarvard Medical SchoolBoston, MassachusettsAlice T. Shaw, MD, PhDChief, Strategic PartnershipsAttending Physician, Thoracic OncologyDana-Farber Cancer InstituteHarvard Medical SchoolBoston, MassachusettsResources:To download the slides associated with this podcast discussion, please visit the program page.

In this episode of Cancer Registry World, we are excited to feature two esteemed colleagues from Health Catalyst: Launa Goodman, Clinical Data Program Manager for Oncology, and Allie Coronis, Senior Vice President of Tech-Enabled Managed Services (TEMS). They delve into the crucial role that cancer and other registries play in meeting the global demand for accurate and meaningful data within healthcare enterprises. Enjoy listening and learning!

In this episode, explore the fascinating world of cholesterol dynamics with Dr. Nick Norwitz as he challenges conventional wisdom. Discover the significance of understanding cholesterol risk profiles, particularly in lean mass hyper-responders on a ketogenic diet.   Dive into Dr. Norwitz's bold “Oreo vs. Statin” study, which uncovers surprising insights about cholesterol management. Learn how this experiment highlights the need to reassess traditional approaches to heart health.   Gain valuable knowledge on why LDL cholesterol should not be the sole focus when evaluating cardiovascular risk. Understand the importance of a holistic view that considers individual metabolic health. In This Episode:   00:00 Understanding LDL and Cardiovascular Risk 04:08 Episode Overview: Oreo Cookie Study 07:24 Interview with Dr. Nicholas Norowitz 08:20 The Oreo Cookie Experiment 15:59 Exploring the Lean Mass Hyper Responder Phenomenon 34:43 Understanding VLDL and Triglyceride Metabolism 35:28 The Triad: LDL, HDL, and Triglycerides 36:36 Exploring the Lipid Energy Model 37:30 Insulin's Role in Fat Metabolism 38:22 Clinical Data and Metabolic Profiles 41:20 The Controversy of LDL Particles 46:26 The Lean Mass Hyper Responder Phenotype 52:49 Personal Journey with Ketogenic Diet 58:01 Side Effects of Statin Drugs 01:02:20 Satiety Per Calorie and Marketing Tactics 01:07:47 Conclusion and Final Thoughts   This episode is sponsored by Paleo Valley and their Organic Supergreens powder, a product I love for its high chlorophyll content, which supports blood purification, detoxification, and mitochondrial health. Packed with digestive-supportive superfoods like ginger, lemon, and beet, it's free from cereal grasses, making it gentle on the gut, especially for those with chronic inflammation.   I mix a scoop in water daily, usually after lunch, for an energy boost and mental clarity. You can save 15% on any Paleo Valley product, including their Organic Supergreens, by visiting paleovalley.com/jockers     This podcast is sponsored by ShopC60.com. C60 is a powerful, Nobel Prize-winning antioxidant that helps to optimize mitochondrial function, fights inflammation, and neutralizes toxic free radicals! I'm a big fan of using C60 in conjunction with your keto and intermittent fasting lifestyle to support your immune system, help your body detox, and increase energy and mental clarity. My favorite C60 products for Keto & IF lifestyles include C60 Purple Power in Organic MCT Coconut Oil (you can add this to your coffee) and their delicious Sugar-Free C60 Gummies (made with allulose and monk fruit)! If you are over the age of 40, and you'd like to kick fatigue and brain fog to the curb this year, visit shopc60.com and use the coupon code “JOCKERS” for 15% OFF  and start taking back control over your health today!     “The physiology behind lean mass hyper-responders is an incredible natural experiment, a gift to science.” -Dr. Nick Norwitz   Subscribe to the podcast on: Apple Podcast Stitcher Spotify PodBean  TuneIn Radio     Resources: Visit https://shopc60.com/jockers – Use code “JOCKERS” to get 15% off! Paleovalley's Supergreens - visit paleovalley.com/jockers Oreo Study - https://pubmed.ncbi.nlm.nih.gov/38276308/ Don't be Fooled! A Lesson in Unmasking Pseudoscience - https://www.youtube.com/watch?v=1IWCmFgThQA     Connect with Dr. Nick Norwitz: Twitter: https://x.com/nicknorwitz  Instagram: https://www.instagram.com/nicknorwitz/ YouTube: https://www.youtube.com/channel/UCLTZUJSEulehPtF_ytFiU_A?sub_confirmation=1 Newsletter: https://staycuriousmetabolism.substack.com/   Connect with Dr. Jockers: Instagram – https://www.instagram.com/drjockers/ Facebook – https://www.facebook.com/DrDavidJockers YouTube – https://www.youtube.com/user/djockers Website – https://drjockers.com/   If you are interested in being a guest on the show, we would love to hear from you! Please contact us here! - https://drjockers.com/join-us-dr-jockers-functional-nutrition-podcast/  

Payers need access to timely, accurate member data for their quality reporting needs

CME credits: 1.25 Valid until: 28-06-2025 Claim your CME credit at https://reachmd.com/programs/cme/from-trial-to-treatment-translating-emerging-clinical-data-into-meaningful-schizophrenia-clinical-care/26603/ Despite the advances that have been made with atypical antipsychotics indicated for the treatment of schizophrenia (SCZ), significant safety and efficacy concerns persist with these D2 blockers. Inadequate response to these treatments is common. Several emerging agents are undergoing phase 3 clinical trials. These new treatments possess unique mechanisms of action, encouraging efficacy profiles across positive, negative, and cognitive domains and favorable safety profiles that offer new hope for those living with SCZ. This educational series will cover accurately identifying individuals, including those in unique patient populations, who may benefit from switching to or augmentation with an emerging treatment option, how and when to incorporate switching or augmentation strategies, and how to integrate new therapies into current clinical practice.

Broderick Chavez joins Dave Crosland & Scott McNally to talk all things PED Chapters: 00:00:00 - The Chemical Alteration of Testosterone and its Effects 00:02:35 - An Introduction to Broderick Chavez 00:04:55 - The Beginning of His Fitness Journey 00:07:37 - Developing a Desire for Knowledge 00:10:05 - Training Themes and Cycles 00:12:31 - The History of Steroids and Their Similarities 00:15:12 - The Role of Enzymes in Steroid Metabolism 00:17:49 - The Discovery of Aromatase Enzyme Inhibitors 00:23:04 - A Discussion on Coffee Preferences and Magic Tricks 00:25:37 - Misinterpretation of Research 00:28:10 - Over-relying on Clinical Data 00:30:39 - Open-mindedness and accepting being wrong 00:35:43 - Acid Reflux and Tren Ace 00:38:31 - Training Split for Shift Workers 00:44:03 - The History of Site Injections in Bodybuilding 00:46:26 - Starting a Steroid Cycle 00:49:01 - A Deal with the Devil 00:51:37 - The Risks of Over-taxing Organs in Bodybuilding 00:54:09 - The disconnect in bodybuilding training 00:56:32 - The Importance of Effort and Durability in Training 00:59:04 - Team Evil GSP Branding ✅ Follow Broderick : https://www.instagram.com/teamevilgsp/ ✅ Amino Asylum code THINK for 20% off research chems, peptides, l-carnitine and more https://aminoasylum.shop/ref/122/

In this episode, Matt Iorio at Neuros Medical and Duane Mancini discuss his background in the Medtech space, the collection of clinical data, the importance of clinical data for regulatory and commercial purposes, and so much more.

The rise of generative AI has impacted healthcare in many ways – one of which is that it's pushing Big Tech toward becoming not just a relevant, but a central player in the industry. And when we're talking Big Tech, we have to include Google. Google's activity in healthcare has been turbulent since it entered the space nearly two decades ago, but it's impossible to deny the significance of the contributions it's made to the industry. Now with the rapid growth of genAI, Google is refining its healthcare strategy to drive maximum impact in the areas it's best positioned to – places like consumer, therapeutics, diagnostics, and more. At the forefront of this work is Dr. Karen DeSalvo, Google's Chief Health Officer. This week, guest host Eric Larsen, President Emeritus of Advisory Board and President of Towerbrook Advisors sits down with Dr. DeSalvo to unpack the seemingly boundless opportunities of generative AI to evolve healthcare and the unique—and scoped—role Google is playing in helping advance that evolution. Links: Lessons from the C-suite AI in healthcare: Insights from 10 C-suite executives Ep. 197: Lessons from the C-Suite: Demystifying generative AI with Dr. John Halamka, President of Mayo Clinic Platform Ep. 185: AI adoption: why you can't afford to "wait and see" Ep. 180: Tom Lawry on why AI has a PR problem The chronic condition we should be talking about: Challenges and opportunities in migraine care Learn about Advisory Board Fellowship A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/CPD information, and to apply for credit, please visit us at PeerView.com/CAN865. CME/CPD credit will be available until 5 June 2025.Five Steps for Integrating BCMA Bispecific Innovations: From Clinical Data to Clinical Practice in RRMM In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Pfizer.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/CPD information, and to apply for credit, please visit us at PeerView.com/CAN865. CME/CPD credit will be available until 5 June 2025.Five Steps for Integrating BCMA Bispecific Innovations: From Clinical Data to Clinical Practice in RRMM In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Pfizer.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/CPD information, and to apply for credit, please visit us at PeerView.com/CAN865. CME/CPD credit will be available until 5 June 2025.Five Steps for Integrating BCMA Bispecific Innovations: From Clinical Data to Clinical Practice in RRMM In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Pfizer.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/CPD information, and to apply for credit, please visit us at PeerView.com/CAN865. CME/CPD credit will be available until 5 June 2025.Five Steps for Integrating BCMA Bispecific Innovations: From Clinical Data to Clinical Practice in RRMM In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Pfizer.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/CPD information, and to apply for credit, please visit us at PeerView.com/CAN865. CME/CPD credit will be available until 5 June 2025.Five Steps for Integrating BCMA Bispecific Innovations: From Clinical Data to Clinical Practice in RRMM In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Pfizer.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/CPD information, and to apply for credit, please visit us at PeerView.com/CAN865. CME/CPD credit will be available until 5 June 2025.Five Steps for Integrating BCMA Bispecific Innovations: From Clinical Data to Clinical Practice in RRMM In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Pfizer.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/CPD information, and to apply for credit, please visit us at PeerView.com/CAN865. CME/CPD credit will be available until 5 June 2025.Five Steps for Integrating BCMA Bispecific Innovations: From Clinical Data to Clinical Practice in RRMM In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Pfizer.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/CPD information, and to apply for credit, please visit us at PeerView.com/CAN865. CME/CPD credit will be available until 5 June 2025.Five Steps for Integrating BCMA Bispecific Innovations: From Clinical Data to Clinical Practice in RRMM In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Pfizer.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/CPD information, and to apply for credit, please visit us at PeerView.com/CAN865. CME/CPD credit will be available until 5 June 2025.Five Steps for Integrating BCMA Bispecific Innovations: From Clinical Data to Clinical Practice in RRMM In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Pfizer.Disclosure information is available at the beginning of the video presentation.

In this special bonus clip from our Excellence Spotlight series, Sr. Director of Data Operations (Clinical Trials) Noel Keegan takes a deep dive into clinical data management. From the transition to electronic systems to the exciting potential of AI, Noel reflects on the evolution he's witnessed over his 16+ year career. He breaks down the key aspects of data management across the study lifecycle:

AI hype is high, but real use cases need exploration for practical applications. In this episode, Saul Marquez interviews Latif Khalil, CEO, and Nagesh (Dragon) Bashyam, CTO, of InteropX at HIMSS 2024, where they aim to connect with customers face-to-face and stay updated on healthcare technology trends. InteropX, founded in 2016, specializes in creating virtual data pipelines between payers and providers, ensuring up-to-date and usable clinical data for value-based care. Latif has extensive experience in technology and company management while Dragon is a technical expert in healthcare standards and regulations, and throughout this conversation, they emphasize the importance of focusing on business operations while letting technology experts handle data integration and maintenance.  They also discuss the growing acceptance of healthcare standards alongside the ongoing exploration of practical applications amidst the persistent AI hype. Tune in and learn how InteropX can streamline data management for improved healthcare outcomes! Resources:  Watch the entire interview here. Connect with and follow Latif Khalil on LinkedIn. Connect with and follow Nagesh Bashyam on LinkedIn. Learn more about InteropX on their LinkedIn and website. Email Latif here.

In order to ensure a fair and accessible future, it's imperative to cut down on healthcare expenses. In this episode, Dan Wilson, founder and CEO of Moxe Health, discusses how their team unlocks the power of clinical data to drive payment and operations. He shares how Moxe is making it easier to share data and insights, which ultimately drives down costs and improves care. Throughout this conversation, Dan unravels Moxe's mission to forge interoperability in healthcare tech, streamline payer-provider relationships, and, most importantly, drive affordability for all. His unique approach sidesteps the typical jargon of software talk and zeroes in on solving real-world problems with human empathy and innovative technology.  Get ready to understand how Moxe is not just a software platform but a beacon for collaboration and efficiency in the complex world of healthcare. Resources:  Find out more about the KLAS thought leadership series here. Watch the entire interview here. Connect with and follow Dan Wilson on LinkedIn. Follow Moxe Health on LinkedIn. Discover the Moxe Health Website.

Dr. Pedro Barata, Director of the Clinical Genitourinary Medical Oncology Research Program at UH Seidman Cancer Center, provides an exclusive round-up of the most groundbreaking and practice-changing research unveiled at the ASCO GU 2024 meeting. With expertise and insight, he delves into pivotal studies such as CheckMate 914 Part B and KEYNOTE-564, exploring their implications for kidney cancer. The episode further unravels the transformative findings from the AMBASSADOR study, shedding light on adjuvant immunotherapy in bladder cancer; genetic testing and FGFR advancements in bladder cancer; life-prolonging therapies and radioligand therapies in castration-resistant prostate cancer; and the latest in minimal residual disease research. Check out Chadi's website for all Healthcare Unfiltered episodes and other content. www.chadinabhan.com/ Watch all Healthcare Unfiltered episodes on YouTube. www.youtube.com/channel/UCjiJPTpIJdIiukcq0UaMFsA

This Conversations in MF podcast will discuss the most clinically relevant data and emerging strategies into practice to improve outcomes for patients with MF presented from the 2023 international meetings of the American Society of Clinical Oncology (ASCO), European Hematology Association (EHA) and Society of Hematologic Oncology (SOHO).Launch Date: January 29, 2024Release Date: January 29, 2024Expiration Date: December 30, 2024FACULTY BIOSPrithviraj Bose, MDProfessor, Department of Leukemia, Division of Cancer MedicineUniversity of TexasMD Anderson Cancer CenterJohn Mascarenhas, MDProfessor of MedicineIcahn School of Medicine at Mount SinaiDirector, Center of Excellence in Blood Cancers and Myeloid DisordersRuben Mesa, MDExecutive DirectorAtrium Health Wake Forest Baptist Comprehensive Cancer CenterThis podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode.https://www.practicepointcme.com/CMEHome/conference-briefs-highlighting-myelofibrosis-clinical-data-from-key-conferences-17

This Conversations in MF podcast will discuss the most clinically relevant data and emerging strategies into practice to improve outcomes for patients with MF presented from the 2023 international meetings of the American Society of Clinical Oncology (ASCO), European Hematology Association (EHA) and Society of Hematologic Oncology (SOHO).Launch Date: January 29, 2024Release Date: January 29, 2024Expiration Date: December 30, 2024FACULTY BIOSPrithviraj Bose, MDProfessor, Department of Leukemia, Division of Cancer MedicineUniversity of TexasMD Anderson Cancer CenterJohn Mascarenhas, MDProfessor of MedicineIcahn School of Medicine at Mount SinaiDirector, Center of Excellence in Blood Cancers and Myeloid DisordersRuben Mesa, MDExecutive DirectorAtrium Health Wake Forest Baptist Comprehensive Cancer CenterThis podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode.https://www.practicepointcme.com/CMEHome/conference-briefs-highlighting-myelofibrosis-clinical-data-from-key-conferences-17

This Conversations in MF podcast will discuss the most clinically relevant data and emerging strategies into practice to improve outcomes for patients with MF presented from the 2023 international meetings of the American Society of Clinical Oncology (ASCO), European Hematology Association (EHA) and Society of Hematologic Oncology (SOHO).Launch Date: January 29, 2024Release Date: January 29, 2024Expiration Date: December 30, 2024FACULTY BIOSPrithviraj Bose, MDProfessor, Department of Leukemia, Division of Cancer MedicineUniversity of TexasMD Anderson Cancer CenterJohn Mascarenhas, MDProfessor of MedicineIcahn School of Medicine at Mount SinaiDirector, Center of Excellence in Blood Cancers and Myeloid DisordersRuben Mesa, MDExecutive DirectorAtrium Health Wake Forest Baptist Comprehensive Cancer CenterThis podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode.https://www.practicepointcme.com/CMEHome/conference-briefs-highlighting-myelofibrosis-clinical-data-from-key-conferences-17

Laura Timbrook joins Erin and Laura to discuss improving sleep for shift workers, focusing on tailored support, circadian rhythms, and social connection. In this enlightening episode, Laura Timbrook takes us on a journey toward client-centric sleep solutions for shift workers. She discusses the importance of understanding individual needs and preferences when crafting sleep recommendations. She also explores innovative approaches to enhance overall wellness for those navigating irregular work hours. From circadian rhythm hacks to personalized sleep routines, Laura guides us through a comprehensive roadmap to better support our shift-working clients. Connect with Laura on: Website: https://lauratimbrook.com/ LinkedIn: https://www.linkedin.com/in/lauratimbrook/ Instagram: http://instagram.com/lauratimbrook Podcast: https://open.spotify.com/show/55O5N3KuovQ0PT2X5HmC3L YouTube: https://www.youtube.com/channel/UCyA2oMM9oqorl8UcRAgVo_A/videos Episode Overview: 0:00:00 Introducing Laura Timbrook, expert on helping shift workers 0:02:33 The wellness industry's slow response to shift workers' needs 0:06:01 Shift work's impact on cardiovascular health and reasons behind it 0:08:20 Laura's creation of a Better Sleep course for health coaches 0:11:26 Challenges and misconceptions about shift work and health 0:16:45 Noise-canceling blankets for better sleep during the day 0:25:05 Basement: A Solution for Better Sleep 0:26:44 Creating a Sleep Sanctuary 0:29:09 Addressing Shift Work from both Employee and Employer Perspectives 0:32:18 The Need for Clinical Data to Quantify Shift Work Improvements 0:35:14 The Challenges of Long Shifts in Various Industries 0:41:41 Mindset Change: From No Vegetables to One Leaf of Spinach 0:44:01 Starting Small: The Power of One Small Change 0:47:26 The Shift HC Course and Better Sleep Course: Overview and Focus 0:51:48 The Heartbreak of Missing Out on Family Time 0:52:46 The Confusion Surrounding Breakfast

In this episode of Cancer Registry World, we welcome Lisa Robinson, RHIA, CTR, Director of Clinical Data Registries for Advocate Health Care, Midwest Region. Ms. Robinson discusses the importance of cancer registries in large multi-institutional healthcare systems as well as highlighting the technological advances that may impact registry operations. Enjoy listening and learning!

Drs. Nicholas Torney (@NPT_PharmD) and Sunish Shah join Dr. Jeannette Bouchard (@jlbouchard001) to discuss our next topic in our Dosing Consult series: BID vs TID dosing for metronidazole. Deep dive into the PK/PD and real-world application of this switch with experts in this dosing strategy. References: Addition of anaerobic coverage in biliary infections: Addition of anaerobic coverage for treatment of biliary tract infections: a propensity score-matched cohort study Eggerthella lenta and Pipercillin-tazobactam: Eggerthella lenta Bloodstream Infections Are Associated With Increased Mortality Following Empiric Piperacillin-Tazobactam (TZP) Monotherapy: A Population-based Cohort Study Q12H Dose Schedule in Surgery Prophylaxis: Twelve-hourly dosage schedule for oral and intravenous metronidazole 2018 Clinical Data on Q12H Dosing in Mixed Infections: Clinical efficacy of 12-h metronidazole dosing regimens in patients with anaerobic or mixed anaerobic infections 2021 Clinical Data on Q12H Dosing: Three is a crowd: Clinical outcomes of a twice daily versus a thrice daily metronidazole dosing strategy from a multicenter study Learn more about the Society of Infectious Diseases Pharmacists: https://sidp.org/About Twitter: @SIDPharm (https://twitter.com/SIDPharm) Instagram: @SIDPharm (https://www.instagram.com/sidpharm/) Facebook: https://www.facebook.com/sidprx LinkedIn: https://www.linkedin.com/company/sidp/ SIDP welcomes pharmacists and non-pharmacist members with an interest in infectious diseases, learn how to join here: https://sidp.org/Become-a-Member Listen to Breakpoints on iTunes, Overcast, Spotify, Listen Notes, Player FM, Pocket Casts, Stitcher, Google Play, TuneIn, Blubrry, RadioPublic, or by using our RSS feed: https://sidp.pinecast.co/ Check out our podcast host, Pinecast. Start your own podcast for free with no credit card required. If you decide to upgrade, use coupon code r-7e7a98 for 40% off for 4 months, and support Breakpoints.

Billy Meadow is the Founder and Chairman and Peter vonDyck is the President and CEO of PERSOWN Inc., a medical information technology and diagnostics company that provides the first of its kind low-cost comprehensive family health diagnostic solution delivered within a smartphone app with global access. In this episode Billy, Peter and KJ discuss their technology that aims to unify clinical data in real-time to improve patient care, prevent sepsis, and reduce false positive fatigue. They also discuss the potential economic benefits, improved quality of care, and increased trust in hospitals that could result from this unified data.    Key Takeaways: The challenges of data and care fragmentation in healthcare systems The impact of unifying electronic health records and remote patient monitoring The real-world effects of unified data on the economy and quality of care The importance of affordability and accessibility of technology in developing countries   Quote of the Show (44:00): "I think people are going to feel a lot healthier in just a matter of a few years because the tools are out there that will enable us to all feel better, catch different disease conditions a lot earlier and live longer, healthier lives." – Billy Meadow   Join our Anti-PR newsletter where we're keeping a watchful and clever eye on PR trends, PR fails, and interesting news in tech so you don't have to. You're welcome.   Want PR that actually matters? Get 30 minutes of expert advice in a fast-paced, zero-nonsense session from Karla Jo Helms, a veteran Crisis PR and Anti-PR Strategist who knows how to tell your story in the best possible light and get the exposure you need to disrupt your industry. Click here to book your call: https://info.jotopr.com/free-anti-pr-eval   Ways to connect with Billy Meadow: LinkedIn: https://www.linkedin.com/in/billy-meadow-b8181610/ Company Website: https://persown.com/       Ways to connect with Peter vonDyck: LinkedIn: https://www.linkedin.com/in/peter-vondyck-4ab364b/ Company Website: https://persown.com/       How to get more Disruption/Interruption:  Amazon Music - https://music.amazon.com/podcasts/eccda84d-4d5b-4c52-ba54-7fd8af3cbe87/disruption-interruption Apple Podcast - https://podcasts.apple.com/us/podcast/disruption-interruption/id1581985755 Google Play - https://podcasts.google.com/feed/aHR0cHM6Ly93d3cub21ueWNvbnRlbnQuY29tL2QvcGxheWxpc3QvODE5NjRmY2EtYTQ5OC00NTAyLThjZjktYWI3YzAwMmRiZTM2LzNiZTZiNzJhLWEzODItNDhhNS04MDc5LWFmYTAwMTI2M2FiNi9kZDYzMGE4Mi04ZGI4LTQyMGUtOGNmYi1hZmEwMDEyNjNhZDkvcG9kY2FzdC5yc3M= Spotify - https://open.spotify.com/show/6yGSwcSp8J354awJkCmJlDSee omnystudio.com/listener for privacy information.

On this episode I was joined by Margaret Jenkins, who's the Founder and Principal at Global Pharma Solutions. Margaret and I discuss: Clinical Data interpretation and authoring eCTD Module 2 Overview Learning drug assays with a device background Non-Clinical eCTD Module 4 Clinical eCTD Module 5 Margaret Jenkins is the Founder and Principal at Global Pharma Solutions where she works closely with clients to provide strategic solutions, allowing them to follow the most efficient pathway to registration and launch in their chosen markets. Margaret has more than 30 years' experience in the Pharmaceutical industry both in the UK and Australia, spanning drug discovery, drug development and Regulatory Affairs.Margaret has hands-on experience in numerous successful global submissions in both the innovator and generic spaces for: US, EU, Asia Pacific and ANZ. Margaret has written all 5 modules of the CTD including writing clinical overviews and summaries, several module 3s (CMC), and summarizing pre-clinical reports.

In this episode, we hear clips from four interviews recorded live at NCQA's 2nd annual Health Innovation Summit.Parker Holcomb is Chief AI Engineer at Elevance Health. At NCQA's 2023 Health Innovation Summit, he participated in a session titled “Building Trust in Clinical Data for Value-Based Care”. Parker stands at the forefront of data quality, constantly seeking to perfect data quality standards, all towards closing gaps in health equity. So how do professionals and technologists align the movement toward digital health transformation in the direction of value-based care?Dr. Joseph Betancourt is president of the Commonwealth Fund. One of the nation's preeminent leaders in health care quality, Dr. Betancourt formerly served as senior vice president for Equity and Community Health at Massachusetts General Hospital (MGH), overseeing a number of entities including the Center for Diversity and Inclusion.A prolific author, lecturer, and board-certified internist who focuses on Spanish-speaking and minority populations, Dr. Betancourt is also an associate professor of medicine at Harvard Medical School. This is notable for this interview, as he earned his MPH from Harvard with one of the first classes in the Commonwealth Fund–Harvard University Fellowship in Minority Health Policy.At the 2023 NCQA Health Innovation Summit, he led a session titled “Pursuing the North Star: A high performing, equitable health care system”. And as you'll hear, increasing diversity among health care professionals and rebuilding the trust of historically under-served patients are just two of a myriad of ingredients necessary to right the ship on the journey to Health Equity.Next, we hear a success story from a team from WellSpan Health, a health care that found a gap in health care equity and nailed down a solid and sustainable solution.Jenna Jansen is the Senior Director of Quality at WellSpan Health.Jodi Cichetti is Vice President, Quality and Patient Safety, at Wellspan Health.Jenna and Jodi presented a session at the Health Innovation Summit titled “STOP, Collaborate, & LISTEN! Improving equitable access to care”. In the interview, they told the story of how their research revealed a gap in care delivery. Using various analytical tools including NCQA's breast cancer screening measure, part of our HEDIS set of measures, they discovered a disparity among Spanish-speaking patients.Christopher J. King is the inaugural Dean of the School of Health and former Chair of the Department of Health Systems Administration at Georgetown University in Washington, DC. An academic administrator, associate professor, and strategist, who is board certified in healthcare, Dr. King's writing and teaching focus on the intersection of institutional racism, social determinants of health, and healthcare administration. And he envisions a world in which health status cannot be predicted by race, social class or place of residence.At this year's NCQA Health Innovation Summit, Dr. King joined the dais in a session titled “No Quality without Equity”. In this clip from our interview, Dr. King talks about race-based clinical data in health care. And in his view, the use of this data is doing more harm than good.Stay tuned for more information about NCQA's next Health Innovation Summit, set for Nashville, October 31-November 2, 2024. For more, go to https://www.ncqasummit.com.

S1 E23: Bridging the gap between payers and providers through better clinical data exchange. How can technology improve the relationship between payers and providers? Is there anything we can do to remove cost, abrasion and redundancy? Host Beth Friedman talks with Jason Brown, CEO at MRO, about advancements his company is making to automate the cumbersome process of healthcare clinical data exchange . MRO manages the secure, accurate and efficient fulfillment of patient data and medical record requests between patients, providers, payers and other consumers of clinical data. The company won Best in KLAS for ten years, received a KLAS 1000 Points of Light award, and has been recognized on the Inc. 5000 List for nine years in a row. Tune in to hear how Brown and his team at MRO use innovative technology and workflows to simplify clinical data exchange within the payer-provider relationship. To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play Healthcare NOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

Join us in a riveting conversation with Nicole Kemble and Michele Barrila-Yetman, who are clinical data coordinators at the Children's Hospital of Philadelphia. Discover how they maintain data integrity with meticulous quality control and documentation tactics, including facilitating a data advisory committee, and how they've created a supportive environment for new institutions through a training and mentoring subcommittee.But there's more to their roles than just data input. Nicole and Michele offer an exciting peek into the world of healthcare data analysis, sharing the techniques they employ to spot trends and make critical decisions. They also share their innovation in tracking the rise of telemedicine, ensuring that no valuable data slips through the cracks. So, if you've ever been curious about the world of healthcare data and its real-world impact – this episode is a treasure trove of insights. As always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

The Florida Department of Health has Boldly Recommended Against the COVID Booster for People Under 65 years old, Citing the Lack of Clinical Data. Dr. Joseph Ladapo Joins the Program To Discuss Why; The FDA Has Approved the COVD Booster With Virtually No Data. Jefferey Jaxen Breaks Down The Shocking Numbers They DO Have; A New ‘Fruit Film' Lacks appeal; Oncologist, Dr. William Makis, Explores Potential, and Very Possible, Pathways by Which mRNA Vaccines Are Triggering ‘Turbo Cancers.' Guests: Joseph A. Ladapo, M.D., Ph.D., William Makis, M.D.